Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?

In the following report, we describe a case of alkaline phosphatase (ALP) elevation occurring during treatment with alectinib (Alecensa™), which was administered for anaplastic lymphoma kinase (ALK) mutated metastatic non-small cell lung cancer (mNSCLC). A 51 year-old female with widespread metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalata, Walid, Yakobson, Alexander, Steckbeck, Rachel, Jama, Ashraf Abu, Abu Saleh, Omar, Agbarya, Abed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774469/
https://www.ncbi.nlm.nih.gov/pubmed/35049690
http://dx.doi.org/10.3390/curroncol29010016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774469/
https://www.ncbi.nlm.nih.gov/pubmed/35049690
http://dx.doi.org/10.3390/curroncol29010016

Ejemplares similares